Related Experiment Videos
Cytokines in Parkinson's disease
T Nagatsu1, M Mogi, H Ichinose
1Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Aichi, Japan. tnagatsu@fujita-hu.ac.jp
Summary
Parkinson's disease (PD) is linked to increased cytokines and apoptosis proteins in the brain and cerebrospinal fluid. These molecular changes may drive the degeneration of dopamine neurons in PD.
Area of Science:
- Neuroscience
- Molecular Biology
- Pathology
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra.
- The precise molecular mechanisms underlying neurodegeneration in PD remain incompletely understood.
- Cytokines, neurotrophins, and apoptosis-related proteins are implicated in neuronal health and disease.
Purpose of the Study:
- To investigate the levels of various cytokines, neurotrophins, and apoptosis-related proteins in the brain and cerebrospinal fluid of Parkinson's disease patients.
- To examine the changes in these molecular markers in animal models of Parkinson's disease, including MPTP-induced parkinsonism and 6-OHDA-induced hemiparkinsonism.
- To explore the potential role of these molecular alterations in the pathogenesis of nigrostriatal dopaminergic neuron degeneration.
Main Methods:
- Analysis of postmortem brain tissue (striatum) and cerebrospinal fluid (ventricular and spinal) from PD patients and controls.
- Measurement of cytokine levels (TNF-alpha, IL-1beta, IL-2, IL-4, IL-6, EGF, TGF-alpha, TGF-beta1) and apoptosis-related proteins (bcl-2, sFas).
- Utilized MPTP-treated mice and 6-OHDA-lesioned rats to model PD, assessing striatal and substantia nigra levels of IL-1beta, NGF, and TNF-alpha.
Main Results:
- Significantly elevated levels of multiple cytokines and apoptosis-related proteins were observed in the striatum and cerebrospinal fluid of PD patients.
- MPTP-treated mice showed increased striatal IL-1beta and decreased NGF levels.
- 6-OHDA-lesioned rats exhibited increased TNF-alpha in the striatum and substantia nigra, which was not altered by L-DOPA treatment.
Conclusions:
- The study suggests that altered levels of cytokines, neurotrophins, and apoptosis-related proteins in the nigrostriatal region are associated with Parkinson's disease.
- These molecular changes may play a significant role in the apoptosis and degeneration of dopaminergic neurons observed in PD.
- The findings highlight potential therapeutic targets for mitigating neurodegeneration in Parkinson's disease.